Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 2.54 HKD 0.79% Market Closed

Market Cap: HK$7.5B

S	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd HKEX:1349	CN
B	Bitcoin Group SE SWB:ADE	DE
	Mydecine Innovations Group Inc F:0NF0	CA
	Menicon Co Ltd F:5FR	JP
B	Braime Group PLC LSE:BMT	UK
	Minera IRL Ltd F:DZX	PE
D	Daphne International Holdings Ltd XMUN:PSX	CN
	AnorTech Inc F:HR50	CA
	Daiseki Co Ltd OTC:DSKIF	JP
	Adastria Co Ltd F:1E0	JP

Profitability Summary

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

90%

Strong 3Y Average Gross Margin

90%

Declining Gross Margin

92% > 90%

Negative Operating Margin

-17%

Negative 3Y Average Operating Margin

-1%

Declining Operating Margin

20% > -17%

Negative Net Margin

-19%

Low 3Y Average Net Margin

Declining Net Margin

19% > -19%

Exceptional Free Cash Flow Margin

21%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.